Clinical Trial

Expanded Access of Occlutech's Atrial Flow Regulator

Available
View on ClinicalTrials.gov →
Summary
Occlutech AFR use allowed per FDA's Expanded Access program.
Trial Details
NCT Number NCT07421557
Lead Sponsor Occlutech International AB
Updated on ClinicalTrials.gov 2026-02-19